Conformationally Restricted Macrocycles as Improved FKBP51 Inhibitors Enabled by Systematic Linker Derivatization
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202418511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Moritz Spiske und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University Darmstadt Peter-Grünberg Strasse 4, 64287, Darmstadt, Germany. Hauptthemen laut MEDLINE: Macrocyclic Compounds, Tacrolimus Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Macrocycles are increasingly considered as promising modalities to target challenging intracellular proteins. However, strategies for transitioning from active linear starting points to improved macrocycles are still underdeveloped. Here we explored the derivatization of linkers as an approach for macrocycle optimization. Using the FK506‐binding protein 51 (FKBP51) as a model system we prepared >140 macrocycles with systematically derivatized linkers. Two backbones were identified as promising frameworks for subsequent optimization. Surprisingly, co‐crystal structure analyses revealed that these chemical templates represent an ensemble of three‐dimensional (3D) conformations that can give rise to several distinct 3D‐scaffolds. This resulted in a set of macrocycles with consistently improved affinity, plasma stability, and aqueous solubility compared to the linear precursors or the non‐functionalized macrocycles. Our results highlight linkers as an opportunity for macrocyclic drug development, show how linker derivatization can improve the performance of macrocycles, and emphasizes the need to track macrocyclic scaffold evolution at a three‐dimensional level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University Darmstadt Peter-Grünberg Strasse 4, 64287, Darmstadt, Germany.
- present address: InfectoPharm Arzneimittel und Consilium GmbH, Von-Humboldt-Str. 1, 64646, Heppenheim, Germany.
- present address: Institute of Structural Biology, University of Bonn, Venusberg Campus 1, 53127, Bonn, Germany.
- Center for Synthetic Biology, Technical University Darmstadt, Darmstadt, Germany.
ORCID-Profile: Felix Hausch
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Spiske, M., Meyners, C., Bauder, M., Repity, M., Brudy, C., Sugiarto, W. O., Achaq, H., Geiger, T. M., & Hausch, F. (2025). Conformationally Restricted Macrocycles as Improved FKBP51 Inhibitors Enabled by Systematic Linker Derivatization. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202418511
Vancouver
Spiske M, Meyners C, Bauder M, Repity M, Brudy C, Sugiarto WO, et al. Conformationally Restricted Macrocycles as Improved FKBP51 Inhibitors Enabled by Systematic Linker Derivatization. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202418511
BibTeX
@article{Spiske2025,
author = {Spiske, Moritz and Meyners, Christian and Bauder, Michael and Repity, Maximilian and Brudy, Christian and Sugiarto, Wisely Oki and Achaq, Hanaa and Geiger, Thomas M and Hausch, Felix},
title = {Conformationally Restricted Macrocycles as Improved FKBP51 Inhibitors Enabled by Systematic Linker Derivatization},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202418511}
}
EUVIMED